Every gram of stored fat holds about nine kilocalories of energy, more than twice the yield of carbohydrate. Yet most of that energy is locked out of the mitochondria, where it would be burned. The inner mitochondrial membrane is one of the most selective barriers in the cell, and long-chain fatty acids cannot cross it on their own.

The cell gets around this with a small, water-soluble molecule called L-carnitine. Without it, fatty acids longer than about fourteen carbons accumulate in the cytoplasm. The heart and skeletal muscle, which draw much of their resting energy from fat, are then left short of fuel. Inherited defects in carnitine transport show how serious this is: they cause cardiomyopathy, muscle weakness, and dangerous hypoglycaemia during fasting.

Outside of supplement marketing, carnitine gets little attention. This article traces how the shuttle works at the molecular level, how the body builds carnitine from amino acids and vitamins, and what the research says about people who eat little or none of it.

When fatty acids enter a cell, they are first activated by acyl-CoA synthetases on the outer mitochondrial membrane. These enzymes use ATP to attach coenzyme A to the fatty acid. The resulting fatty acyl-CoA is ready for oxidation but is too large and polar to pass through the inner membrane. At this point the carnitine palmitoyltransferase (CPT) system takes over.

The transfer happens in three steps. First, CPT1, anchored in the outer membrane, replaces the CoA with carnitine to form an acylcarnitine. Second, the carnitine-acylcarnitine translocase (CACT) in the inner membrane carries the acylcarnitine into the matrix and exports one free carnitine in exchange. Third, CPT2, on the matrix side of the inner membrane, reverses the first reaction. This regenerates acyl-CoA for beta-oxidation and releases carnitine to be recycled outward.

CPT1 is the rate-limiting step, and it is tightly regulated. Its main inhibitor is malonyl-CoA, the first committed intermediate in fatty acid synthesis. After a carbohydrate-rich meal, insulin activates acetyl-CoA carboxylase, malonyl-CoA rises, and CPT1 is suppressed. This stops the cell from building fat and burning it at the same time. During fasting or exercise, AMP-activated protein kinase (AMPK) inhibits acetyl-CoA carboxylase, malonyl-CoA falls, and fatty acids flow into the mitochondria. The liver and muscle use different versions of the enzyme, CPT1A and CPT1B respectively, and they differ in how sensitive they are to this brake.

Carnitine also has a second job that is easy to overlook. Through the enzyme carnitine acetyltransferase, it takes up excess acetyl groups and forms acetylcarnitine. This frees coenzyme A when acetyl-CoA builds up faster than the citric acid cycle can use it. In effect, carnitine buffers the mitochondrial CoA pool. The acylcarnitines that leak into blood and urine also reflect what is happening inside the mitochondria, which is why newborn screening measures them to detect fatty acid oxidation disorders.

Takeaway

The rate of fat oxidation depends less on how much fat is available than on how fast it can cross a membrane. That gate is controlled by a molecule that tells the cell whether it should be building fat or burning it.

Carnitine is classed as conditionally essential. Healthy adults make enough to meet their needs, but production depends on several precursors and cofactors. The carbon backbone comes from lysine. The three methyl groups come from S-adenosylmethionine, which is made from methionine. The lysine is not used in free form. It is methylated while still part of proteins such as histones and calmodulin, and it is released as 6-N-trimethyllysine only when those proteins are broken down.

Four enzymatic steps follow. Trimethyllysine dioxygenase hydroxylates the molecule using iron, 2-oxoglutarate, and vitamin C. An aldolase that depends on pyridoxal phosphate (vitamin B6) then cleaves it. Next, an NAD-dependent dehydrogenase, which relies on niacin, produces gamma-butyrobetaine. A final hydroxylation, which again needs iron and ascorbate, yields L-carnitine. Researchers have proposed that impaired carnitine synthesis contributes to the early fatigue of scurvy. It is an example of the overlapping micronutrient dependencies that Bruce Ames emphasised.

The final step takes place mainly in the liver and kidney. Skeletal muscle holds roughly 95 percent of the body's carnitine but cannot complete synthesis, so it relies on uptake from the blood through the OCTN2 transporter. Mutations in OCTN2 cause primary carnitine deficiency. Secondary deficiency can result from haemodialysis, the anticonvulsant valproate, or pivalate-containing antibiotics, which leave the body bound to carnitine as pivaloylcarnitine.

Endogenous synthesis produces about 0.16 to 0.48 milligrams per kilogram of body weight per day, or roughly 11 to 34 milligrams for a 70-kilogram adult. A typical omnivorous diet adds 60 to 180 milligrams, mostly from red meat, with smaller amounts from dairy, poultry, and fish. The gut absorbs an estimated 54 to 87 percent of dietary carnitine but only about 14 to 18 percent of high-dose supplements. The kidneys reabsorb more than 95 percent of filtered carnitine, so conserving it matters as much as supplying it.

Takeaway

A single molecule can depend on several vitamins, minerals, and amino acids at once, so a marginal shortfall in any one of them rarely shows up in just one pathway.

Plant foods contain very little carnitine, and vegans typically consume around 10 to 12 milligrams a day, a fraction of omnivorous intake. Some plant-based diets also provide less lysine (grain-heavy diets) or methionine (legume-heavy diets), although protein-adequate plant diets generally supply enough of both. Studies consistently find lower plasma carnitine concentrations in vegetarians and vegans than in omnivores.

The body compensates in two ways. Vegetarians reabsorb more carnitine in the kidneys and excrete less in urine, and their synthesis appears to continue normally. Muscle concentrations, which matter most for fat oxidation, are only modestly lower. In a 2016 study, Novakova and colleagues found somewhat lower plasma and muscle carnitine in vegetarian men. Twelve weeks of supplementation raised their levels toward those of omnivores but did not change muscle energy metabolism or exercise performance.

Raising muscle carnitine is difficult because OCTN2 uptake into muscle is already close to saturated at normal plasma concentrations. Work by Wall and colleagues showed how much effort it takes. To raise muscle carnitine in omnivores, participants took about 1.4 grams of carnitine with 80 grams of carbohydrate twice daily for 24 weeks, using the insulin response to drive transport into muscle. More carnitine in the blood does not automatically mean more in the tissue where it is needed.

Gut bacteria add another factor. Intestinal microbes convert unabsorbed carnitine into trimethylamine, which the liver oxidises to trimethylamine N-oxide (TMAO), a compound linked to cardiovascular risk in observational studies. Long-term vegans produce much less TMAO after a carnitine challenge, which reflects differences in their gut microbiota. For healthy vegetarians, current evidence shows no clear benefit from routine supplementation. Supplementation is better justified for diagnosed deficiency, dialysis, or specific medications.

Takeaway

A lower blood level is not the same as a deficiency. What matters is whether the tissue that depends on a nutrient is actually running short.

Carnitine sits at a chokepoint in energy metabolism. Long-chain fats cannot be burned without it, and the cell's nutritional state determines how quickly CPT1 lets them through.

For most people, the system is robust. The liver and kidneys make carnitine from lysine and methionine using vitamin C, B6, niacin, and iron, and the kidneys conserve nearly all of it. In practice, adequate protein and micronutrient intake supports carnitine production more reliably than a supplement does.

Vegetarians maintain lower plasma levels with little evidence of any functional effect. Supplementation clearly helps in genetic deficiency, dialysis, and certain drug therapies. For everyone else, the shuttle usually works well without it.